12/9/2020 8:33:58 AM
Novus Therapeutics Appoints June Lee To Board
11/2/2020 8:14:10 AM
Novus Reports First Patient Enrolled In Phase 2a Trial
of Anti-CD40L Antibody AT-1501 In Amyotrophic Lateral Sclerosis
10/2/2020 11:45:44 AM
Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split
9/14/2020 4:36:31 PM
Novus Therapeutics Announces Acquisition Of Anelixis Therapeutics